These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15351100)

  • 1. Lessons to be learned from clinical studies on hormones and the breast.
    Söderqvist G; von Schoultz B
    Maturitas; 2004 Sep; 49(1):90-6. PubMed ID: 15351100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons to be learned from animal studies on hormones and the breast.
    Clarkson TB; Appt SE; Wood CE; Cline JM
    Maturitas; 2004 Sep; 49(1):79-89. PubMed ID: 15351099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast response to menopausal hormone therapy--aspects on proliferation, apoptosis and mammographic density.
    Conner P
    Ann Med; 2007; 39(1):28-41. PubMed ID: 17364449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgens and the breast.
    von Schoultz B
    Maturitas; 2007 May; 57(1):47-9. PubMed ID: 17386984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroidal hormones and proliferation, differentiation and apoptosis in breast cells.
    Gompel A; Chaouat M; Hugol D; Forgez P
    Maturitas; 2004 Sep; 49(1):16-24. PubMed ID: 15351092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women.
    Hofling M; Hirschberg AL; Skoog L; Tani E; Hägerström T; von Schoultz B
    Menopause; 2007; 14(2):183-90. PubMed ID: 17108847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA; Blake JM; Crosignani PG
    Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of mammographic density in evaluating changes in breast cancer risk.
    Pike MC
    Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():1-5. PubMed ID: 16112948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous progestagens and the human breast.
    Sitruk-Ware R; Plu-Bureau G
    Maturitas; 2004 Sep; 49(1):58-66. PubMed ID: 15351097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.
    Wood CE; Register TC; Lees CJ; Chen H; Kimrey S; Cline JM
    Breast Cancer Res Treat; 2007 Jan; 101(2):125-34. PubMed ID: 16841178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent changes of the ratio of apoptosis to proliferation by norethisterone and medroxyprogesterone acetate in human breast epithelial cells.
    Seeger H; Rakov V; Mueck AO
    Horm Metab Res; 2005 Aug; 37(8):468-73. PubMed ID: 16138258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of mifepristone on breast cell proliferation in premenopausal women evaluated through fine needle aspiration cytology.
    Engman M; Skoog L; Söderqvist G; Gemzell-Danielsson K
    Hum Reprod; 2008 Sep; 23(9):2072-9. PubMed ID: 18579510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of progestogens, by type and regimen, on estrogen-metabolizing enzymes in human breast cancer cells.
    Xu B; Kitawaki J; Koshiba H; Ishihara H; Kiyomizu M; Teramoto M; Kitaoka Y; Honjo H
    Maturitas; 2007 Feb; 56(2):142-52. PubMed ID: 16962266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal testosterone therapy and breast cancer risk.
    Somboonporn W; Davis SR
    Maturitas; 2004 Dec; 49(4):267-75. PubMed ID: 15531122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis.
    Seeger H; Wallwiener D; Mueck AO
    Gynecol Endocrinol; 2008 Oct; 24(10):576-9. PubMed ID: 19012101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density.
    Hofling M; Carlström K; Svane G; Azavedo E; Kloosterboer H; Von Schoultz B
    Gynecol Endocrinol; 2005 Feb; 20(2):110-5. PubMed ID: 15823831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal hormone therapy and risk of breast cancer.
    Chen FP
    Chang Gung Med J; 2009; 32(2):140-7. PubMed ID: 19403003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of sex steroids. Future developments.
    Kuhl H
    Maturitas; 2004 Apr; 47(4):285-91. PubMed ID: 15063481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of tibolone and oestrogen-based HT on breast cell proliferation and mammographic density.
    von Schoultz B
    Maturitas; 2004 Sep; 49(1):S16-21. PubMed ID: 15351103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical markers surrogating on vascular effects of sex steroid hormones.
    Mueck AO; Seeger H
    Gynecol Endocrinol; 2006 Mar; 22(3):163-73. PubMed ID: 16835080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.